Skip to content
GLP-1 Savers
Menu

Head-to-head · Value Score

bmiMD vs NextMeds

Two GLP-1 deals, scored on the same six factors. bmiMD lands a Value Score of 89, NextMeds a 84. Here's who gives you the honest lower price — and where each one bites back.

★ Better value

bmiMD

#11 · Grade A · Great Deal

Est. first month

$99/mo

Save ~93% vs brand-name
Get this deal Full bmiMD review →
VS

NextMeds

#40 · Grade B+ · Good Value

Est. first month

From $129/mo (plus a separate fee, compounded)

Save ~90% vs brand-name
Get this deal Full NextMeds review →

The verdict

Better value: bmiMD

bmiMD takes it on Value Score, 89 to 84 an est. $99/mo first month, with no teaser step-up baked in. NextMeds isn't out of it: Shoppers who want flat-price compounded semaglutide or tirzepatide bundled with a care coach and registered dietitian.

Our #1 overall:Neither of these is our top pick — that's CoreAge Rx (Value Score 93).See why →

Deal-by-deal

The numbers that decide it. Green ✓ marks the stronger side on each line.

DealbmiMDNextMeds
Value Score89 (A)84 (B+)
Est. first month$99/moFrom $129/mo (plus a separate fee, compounded)
Save vs brand-name~93%~90%
Semaglutide$99/moFrom $129/mo (plus a separate fee, compounded)
Tirzepatide$139/moFrom $179/mo (plus a separate fee, compounded)
Both moleculesYesYes
PricingFlat — no step-upWatch
CoverageAll 50 statesAll 50 states

Factor by factor

The six factors behind each Value Score. The orange bar marks the stronger side. See the methodology.

95
Lowest Real Price
86
bmiMD: 95. NextMeds: 86.
84
No Teaser-Rate Bait
72
bmiMD: 84. NextMeds: 72.
98
Nationwide Availability
96
bmiMD: 98. NextMeds: 96.
94
Both Molecules
92
bmiMD: 94. NextMeds: 92.
82
Easy Cancellation
95
bmiMD: 82. NextMeds: 95.
70
Reputation
62
bmiMD: 70. NextMeds: 62.

bmiMD

Sub-$100 semaglutide and a low $139 tirzepatide, flat and nationwide — a straight-up low-price play.

Why it's a deal

  • $99 flat semaglutide and a low $139 tirzepatide
  • Available in all 50 states
  • Both molecules priced up front

The fine print

  • Not LegitScript-certified — do your own pharmacy diligence
  • Thin public track record; no oral or brand-name option

NextMeds

NextMeds is a cash-pay telehealth platform offering compounded semaglutide and compounded tirzepatide on a flat monthly membership — one price bundling the medication (if prescribed), telehealth visits, a…

Why it's a deal

  • Flat monthly membership bundles the medication, telehealth visits, a 1:1 care coach and a licensed registered dietitian — one price, no hidden fees
  • Same price every dose, no auto-renewal, cancel anytime; free shipping and no insurance needed (FSA eligible)
  • Names a compounding pharmacy partner (Foothills Pharmacy) and states it services all 50 states
  • Free, no-obligation online assessment before you pay anything

The fine print

  • Shows a LegitScript 'approval' but links only a generic directory search, not a verifiable seal — we couldn't independently confirm it
  • Promo-driven pricing with a countdown timer and 'price increases' urgency; the standing membership is $129 (sema) / $179 (tirz)
  • A technology platform that coordinates care, not the medical provider; individual clinicians and a medical director aren't named on the site
  • Compounded semaglutide and tirzepatide only — no brand-name (Wegovy/Zepbound) options
  • Compounded GLP-1s are not FDA-reviewed or approved — a different evidence and regulatory tier than brand-name
Get the bmiMD deal Get the NextMeds deal

Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes a Value Score.

Neither one the right fit? Every program that outscores bmiMD is ranked on the bmiMD alternatives board, and the same list for the other side is on alternatives to NextMeds.

More head-to-heads

← All comparisons

Prices, states and verification reflect each program's public disclosures at last check; the Value Score is our editorial judgment per the methodology. “Save vs brand-name” compares the lowest disclosed monthly price against a ~$1,349/mo brand-name cash reference. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.